TB-500 vs Teriparatide

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

Teriparatide

Teriparatide (Forteo) is recombinant human parathyroid hormone (1-34), FDA-approved for osteoporosis treatment. It's unique among osteoporosis drugs in that it stimulates new bone formation.

Full details →

Side-by-Side Comparison

Aspect	TB-500	Teriparatide
Dose Range	2 mg–2.5 mg	20 mcg
Frequency	Less than daily	1x daily
Cycle Length	4–8 weeks	52–104 weeks
Route	subcutaneous	subcutaneous
Mechanism	TB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.	Intermittent PTH exposure paradoxically stimulates osteoblasts more than osteoclasts, resulting in net bone formation. Continuous exposure would cause bone loss, but pulsatile dosing builds bone.
Typical Dosage	Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.	20mcg subcutaneously once daily. Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration	Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.	Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Side Effects	May cause temporary fatigue, headache, or localized irritation at injection sites.	Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Best For	Muscle Growth Recovery & Healing	Recovery & Healing